Tick tock, DEA agents. It’s been three years since you all said you were going to adopt a new attitude, allowing for more and better cannabis testing. But so far you haven’t done anything.
Such was the bone picked with the Drug Enforcement Administration by Paul Armentano, deputy director of the National Organizatino for the Reform of Marijuana Laws (NORML). On Tuesday Armentanon wrote an opinion for The Hill, saying that “the agency has woefully failed to follow through on their pledge.”
In August 20166, the DEA announced that it had a new policy toward cannabis research with an initiative “to increase the number of entities registered under the Controlled Substances Act (CSA) to grow marijuana to supply legitimate researchers in the United States.”
That was welcome news to researchers, pro-cannabis advocates, and a lot of people just generally interested in the health and wellbeing of the millions of people who use cannabis. There is only one federally licensed provider of research cannabis in the United States, the University of Mississippi, and their weed is laughably, notoriously bad.
When Dabs Mag previously reported on the cannabis made at Ole Miss, we called it schwaggy “moldy, yeasty seeds and stems.” To put it in more scientific terms, an analysis from the University of Northern California reported that the weed is so low in THC content that it more closely resembles industrial hemp than it does the cannabis which is stocked in your local pot shop.
To date, the DEA has done almost literally nothing to fulfill its pledge. Armentano writes “Despite having received more than two-dozen applications from private manufacturers seeking DEA licensure to cultivate cannabis, the agency has yet to take action to either affirm or deny a single request.”